Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2006 Oct 18;2006(4):CD003492.
doi: 10.1002/14651858.CD003492.pub2.

Lithium versus antidepressants in the long-term treatment of unipolar affective disorder

A Cipriani  1 , K Smith, S Burgess, S Carney, G Goodwin, J Geddes
Affiliations
Meta-Analysis

Lithium versus antidepressants in the long-term treatment of unipolar affective disorder

A Cipriani et al. Cochrane Database Syst Rev. .

Abstract

Background: The main rationale for the use of lithium in the long-term treatment of unipolar affective disorder is its efficacy in treating bipolar affective disorder and resistant depression. However, there is considerable uncertainty about which pharmacological intervention is most effective in the long-term treatment of recurrent unipolar affective disorder.

Objectives: To assess the effects of lithium versus antidepressants for the long-term treatment of recurrent affective disorder.

Search strategy: We searched the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Registers (CCDANCTR-Studies and CCDANCTR-References) on 2/9/2005. Reference lists of relevant papers and major textbooks of affective disorder were checked. Experts in the field and pharmaceutical companies were contacted regarding unpublished material.

Selection criteria: Randomised controlled trials comparing lithium against antidepressant medication for the long-term treatment of patients with a diagnosis of affective disorder.

Data collection and analysis: Two authors independently assessed trial quality and extracted data. We contacted study authors for additional information. We collected adverse effects information from the trials.

Main results: Eight trials involving 475 people were included. Two of the studies included a mixed group of participants with either bipolar or unipolar disorder. Relapse was defined as admission to hospital and when all kinds of relapses were considered (both depressive and manic), there was a statistically significant difference in favour of lithium (relative risk (RR) fixed effect 0.34, 95% CI 0.14 to 0.82). The results did not exclude the point of no effect, when the random-effects model was used (RR random effects 0.40, 95% CI 0.14 to 1.18). There were no other statistically significant differences between lithium and antidepressants according to all other outcomes considered. Manic or depressive relapse was defined as prescription of non-study medication for mood disorder, manic or depressive relapse (as defined by the study authors), quality of life, social functioning, occupational functioning, overall drop-out rate, drop-out rate due to side-effects, troublesome side-effects, mortality due to all causes and specifically suicides.

Authors' conclusions: There was adequate efficacy evidence for lithium or antidepressants preventing relapse in unipolar affective disorder, however their relative efficacy was unknown. When considering lithium or antidepressant long-term therapy, patients and clinicians should take into account the patient's clinical history, the side-effects and the individual's likely adherence to the recommended treatment regime. Large-scale, long-term randomised trials in unselected groups of subjects with unipolar affective disorder are needed.

PubMed Disclaimer

Conflict of interest statement

AC, KS, SC: none declared. JG and GG have received research support and funding from Sanofi‐Aventis, manufacturers of Priadel (lithium carbonate)

Figures

1.1
1.1. Analysis
Comparison 1 Lithium vs antidepressants, Outcome 1 All relapses.
1.2
1.2. Analysis
Comparison 1 Lithium vs antidepressants, Outcome 2 Depressive relapse.
1.3
1.3. Analysis
Comparison 1 Lithium vs antidepressants, Outcome 3 Manic relapse.
1.4
1.4. Analysis
Comparison 1 Lithium vs antidepressants, Outcome 4 Overall dropout rate.
1.5
1.5. Analysis
Comparison 1 Lithium vs antidepressants, Outcome 5 Dropout rate due to side effects.
1.6
1.6. Analysis
Comparison 1 Lithium vs antidepressants, Outcome 6 Side effects.
1.7
1.7. Analysis
Comparison 1 Lithium vs antidepressants, Outcome 7 Mortality.
1.8
1.8. Analysis
Comparison 1 Lithium vs antidepressants, Outcome 8 Suicide.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Coppen 1976 b {published data only}
    1. Coppen A, Montgomery SA, Gupta RK, Bailey JE. A double‐blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. British Journal of Psychiatry. 128 1976; Vol. 128:479‐85. [MEDLINE: ] - PubMed
    1. Schou M. Lithium as a prophylactic agent in unipolar affective illness: comparison with cyclic antidepressants. Archives of General Psychiatry 1979;36:849‐51. - PubMed
Coppen 1978 b {published data only}
    1. Coppen A, Ghose K, Rao R, Bailey J, Peet M. Mianserin and lithium in the prophylaxis of depression. British Journal of Psychiatry. 133 1978; Vol. 133:206‐10. [MEDLINE: ] - PubMed
    1. Schou M. Lithium as a prophylactic agent in unipolar affective illness: comparison with cyclic antidepressants. Archives of General Psychiatry 1979;36:849‐51. - PubMed
Glen 1981 {published data only}
    1. Glen AI, Johnson AL, Shepherd M. Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double‐blind, controlled trial. Psychological Medicine. 14 1984; Vol. 14, issue 1:37‐50. [MEDLINE: ] - PubMed
    1. Glen I. Lithium and antidepressants in the prophylaxis of depression. Advances in Biological Psychiatry. 7 1981; Vol. 7:208‐17. [MEDLINE: ]
    1. Medical Research Council Drug Trial. Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a controlled clinical trial. A report by the Medical Research Council Drug Trials Subcommittee. Psychological Medicine. 11 1981; Vol. 11:409‐16. [MEDLINE: ] - PubMed
MAP 1986 a {published and unpublished data}
    1. Greil W, Haag M, Huber D, Schmidt S. Maintenance treatment in affective disorders: overview and design of a collaborative study. Pharmacopsychiatry 1986;19(4):167‐9.
    1. Greil W, Ludwig Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, et al. Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. Journal of Affective Disorders. 40 1996; Vol. 40, issue 3:179‐90. [MEDLINE: ] - PubMed
    1. Greil W, Ludwig Mayerhofer W, Steller B, Czernik A, Giedke H, Muller Oerlinghausen B, et al. The recruitment process for a multicenter study on the long‐term prophylactic treatment of affective disorders. Journal of Affective Disorders. 28 1993; Vol. 28, issue 4:257‐65. [MEDLINE: ] - PubMed
    1. Mannel M, Muller‐Oerlinghausen B, Czernik A, Sauer H. 5‐HT brain function in affective disorder: d,l‐fenfluramine‐induced hormone release and clinical outcome in long‐term lithium/carbamazepine prophylaxis. Journal of Affective Disorders 1997;46(2):101‐13. - PubMed
    1. Thies‐Flechtner K, Muller‐Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders Data from a randomized prospective trial. Pharmacopsychiatry 1996;29(3):103‐7. - PubMed
Prien 1984 {published data only}
    1. Frank E, Prien RF, Kupfer DJ, Alberts L. Implications of noncompliance on research in affective disorders. Psychopharmacology Bulletin 1985;21(1):37‐42. - PubMed
    1. Greenhouse JB, Stangl D, Kupfer DJ, Prien RF. Methodologic issues in maintenance therapy clinical trials. Archives of General Psychiatry. 48 1991; Vol. 48, issue 4:313‐8. [MEDLINE: ] - PubMed
    1. Prien RF, Himmelhoch JM, Kupfer DJ. Treatment of mixed mania. Journal of Affective Disorders 1988;15(1):9‐15. - PubMed
    1. Prien RF, Kupfer DJ. Continuation drug therapy for major depressive episodes: how long should it be maintained?. American Journal of Psychiatry 1986;143(1):18‐23. - PubMed
    1. Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate‐imipramine combination. Archives of General Psychiatry. 41 1984; Vol. 41, issue 11:1096‐104. [MEDLINE: ] - PubMed
Quitkin 1978 {published data only}
    1. Kane JM, Quitkin FM, Rifkin A, Ramos Lorenzi JR, Nayak DD, Howard A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo‐controlled comparison. Archives of General Psychiatry. 39 1982; Vol. 39, issue 9:1065‐9. [MEDLINE: ] - PubMed
    1. Quitkin F, Rifkin A, Kane J, Ramos LJ, Klein DF. Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report. American Journal of Psychiatry 1978;135(5):570‐2. - PubMed
    1. Quitkin FM, Kane JM, Rifkin A, Ramos Lorenzi JR, Saraf K, Howard A, et al. Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression: a prospective, placebo‐controlled comparison. Psychopharmacology Bulletin. 17 1981; Vol. 17, issue 1:142‐4. [MEDLINE: ] - PubMed
VA‐NIMH 1970 b {published data only}
    1. DiMascio A. NIMH‐VA Lithium collaborative study. Psychopharmacology Bulletin 1974;10:57‐8.
    1. Pokorny AD, Prien RF. Lithium in treatment and prevention of effective disorder: A VA NIMH collaborative study. Diseases of the Nervous System 1974;35(7):327‐33. - PubMed
    1. Prien R, Caffey E Jr. Relationship between dosage and response to lithium prophylaxis in recurrent depression. American Journal of Psychiatry 1976;133(5):567‐70. - PubMed
    1. Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Archives of General Psychiatry. 29 1973; Vol. 29:420‐5. [MEDLINE: ] - PubMed
    1. Prien RF, Klett CJ, Caffey EM. Lithium prophylaxis in recurrent affective illness. American Journal of Psychiatry. 131 1974; Vol. 131, issue 2:198‐203. [MEDLINE: ] - PubMed
Zanardi 1996 b {published and unpublished data}
    1. Franchini L, Gasperini M, Smeraldi E. A 24‐month follow‐up study of unipolar subjects: a comparison between lithium and fluvoxamine. Journal of Affective Disorders. 32 1994; Vol. 32, issue 4:225‐31. [MEDLINE: ] - PubMed
    1. Zanardi R, Franchini L, Perez J, Smeraldi E. Fluvoxamine and lithium in long‐term treatment of unipolar subjects. XXth Collegium Internationale Neuro psychopharmacologicum, Melbourne, Australia. 1996.

References to studies excluded from this review

Abou‐Salah 1983 {published data only}
    1. Abou‐Salah M, Coppen A. Classification of depression and response to antidepressive therapies. British Journal of Psychiatry. 143 1983; Vol. 143:601‐3. [MEDLINE: ] - PubMed
Ahlfors 1981 {published data only}
    1. Ahlfors UG, Baastrup PC, Dencker SJ, Elgen K, Lingjaerde O, Pedersen V, et al. Flupenthixol decanoate in recurrent manic‐depressive illness. A comparison with lithium. Acta Psychiatrica Scandinavica. 64 1981; Vol. 64, issue 3:226‐37. [MEDLINE: ] - PubMed
Baastrup 1970 {published data only}
    1. Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A. Prophylactic lithium: double blind discontinuation in manic‐depressive and recurrent‐depressive disorders. Lancet. 2 1970; Vol. 2, issue 668:326‐30. [MEDLINE: ] - PubMed
Bauer 2000 {published data only}
    1. Bauer M, Bschor T, Kunz D, Berghofer A, Strohle A, Muller‐Oerlinghausen B. Double‐blind, placebo‐controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry 2000;157(9):1429‐35. - PubMed
Blackwell 1971 {published data only}
    1. Blackwell B. Lithium prophylaxis in recurrent affective disorders. British Journal of Psychiatry. 118 1971; Vol. 118, issue 542:131‐2. [MEDLINE: ] - PubMed
Coppen 1971 {published data only}
    1. Coppen A, Noguera R, Bailey J, Burns BH, Swani MS, Hare EH, et al. Prophylactic lithium in affective disorders. Controlled trial.. Lancet. 2 1971; Vol. 2, issue 719:275‐9. [MEDLINE: ] - PubMed
Coppen 1973 {published data only}
    1. Coppen A, Peet M, Bailey J, Noguera R, Burns BH, Swani MS, et al. Double‐blind and open prospective studies on lithium prophylaxis in affective disorders.. Psychiatry, Neurology and Neurosurgery. 76 1973; Vol. 76, issue 6:501‐10. [MEDLINE: ] - PubMed
DiMascio 1974 {published data only}
    1. DiMascio A. NIMH‐VA Lithium collaborative study. Psychopharmacology Bulletin. 10 1974; Vol. 10:57‐8. [MEDLINE: ]
Fieve 1968 {published data only}
    1. Fieve RR, Platman SR, Plutchik RR. The use of lithium in affective disorders. II. Prophylaxis of depression in chronic recurrent affective disorder. American Journal of Psychiatry. 125 1968; Vol. 125, issue 4:492‐8. [MEDLINE: ] - PubMed
Gram 1972 {published data only}
    1. Gram LF, Rafaelsen OJ. Lithium treatment of psychotic children and adolescents. A controlled clinical trial. Acta Psychiatrica Scandinavica. 48 1972; Vol. 48, issue 3:253‐60. [MEDLINE: ] - PubMed
Hardy 1997 {published data only}
    1. Hardy BG, Shulman KI, Zucchero C. Gradual discontinuation of lithium augmentation in elderly patients with unipolar depression. Journal of Clinical Psychopharmacology. 17 1997; Vol. 17, issue 1:22‐6. [MEDLINE: ] - PubMed
Hoencamp 1994 {published data only}
    1. Hoencamp E, Haffmans PMJ, Dijken WA, Hoogduin CA, Nolen WA, Dyck R. Brofaromine versus lithium addition to maprotiline A double‐blind study in maprotiline refractory depressed outpatients. Journal of Affective Disorders 1994;30(3):219‐27. - PubMed
Joffe 1992 b {published data only}
    1. Joffe RT, Singer W. Thyroid hormone use to enhance the effects of drugs. Clinical Neuropharmacology 1992;15(Suppl 1):389A‐390A. - PubMed
Linder 1989 {published data only}
    1. Linder J, Fyro B, Pettersson U, Werner S. Acute antidepressant effect of lithium is associated with fluctuation of calcium and magnesium in plasma. A double‐blind study on the antidepressant effect of lithium and clomipramine. Acta Psychiatrica Scandinavica. 80 1989; Vol. 80, issue 1:27‐36. [MEDLINE: ] - PubMed
Lingjaerde 1973 {published data only}
    1. Lingjaerde O. Synergistic effect of tricyclic antidepressants and lithium carbonate in endogenous depression. Lancet. 2 1973; Vol. 2, issue 840:1260. [MEDLINE: ] - PubMed
Lingjaerde 1974 {published data only}
    1. Lingjaerde O, Edlund AH, Gormsen CA, Gottfries CG, Haugstad A, Hermann IL, et al. The effects of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. A double‐blind, multicenter trial. Acta Psychiatrica Scandinavica. 50 1974; Vol. 50, issue 2:233‐42. [MEDLINE: ] - PubMed
Linnoila 1984 {published data only}
    1. Linnoila M, Miller TL, Bartko J, Potter WZ. Five antidepressant treatments in depressed patients. Effects on urinary serotonin and 5‐hydroxyindoleacetic acid output. Archives of General Psychiatry 1984;41(7):688‐92. - PubMed
Melia 1970 {published data only}
    1. Melia PI. Prophylactic lithium: a double‐blind trial in recurrent affective disorders. British Journal of Psychiatry. 116 1970; Vol. 116, issue 535:621‐4. [MEDLINE: ] - PubMed
Mendels 1972 {published data only}
    1. Mendels J, Secunda SK, Dyson WL. A controlled study of the antidepressant effects of lithium carbonate. Archives of General Psychiatry. 26 1972; Vol. 26, issue 2:154‐7. [MEDLINE: ] - PubMed
Murphy 1975 d {published data only}
    1. Murphy DL, Brand E, Baker M, Kammen D, Gordon E. Phenelzine effects in hospitalized unipolar and bipolar depressed patients: Behavioral and biochemical relationships. Excerpta Medica 1975;359:788‐99.
Nahunek 1971 {published data only}
    1. Nahunek K, Svestka J, Rodova A. To the antidepressive properties of lithium and its place in the group of antidepressive drugs. Activitas Nervosa Superior. 13 1971; Vol. 13, issue 3:169‐70. [MEDLINE: ] - PubMed
Noyes 1974 {published data only}
    1. Noyes R, Dempsey GM, Blum A, Cavanaugh GL. Lithium treatment of depression. Comprehensive Psychiatry. 15 1974; Vol. 15, issue 3:187‐93. [MEDLINE: ] - PubMed
Peselow 1990 {published data only}
    1. Peselow ED, Dunner DL, Fieve RR. Psychopharmacology in clinical practice: The prophylaxis of unipolar depression. LITHIUM. 1 1990; Vol. 1, issue 2:115‐23. [MEDLINE: ]
Prien 1973 (b) {published data only}
    1. Prien RF, Caffey EM, Klett CJ. Prophylactic efficacy of lithium carbonate in manic‐depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Archives of General Psychiatry. 28 1973; Vol. 28:337‐41. [MEDLINE: ] - PubMed
Schou 1972 {published data only}
    1. Schou M. Lithium prophylaxis in recurrent endogenous affective disorders. Archivos de Investigacion Medica. 3 1972; Vol. 3, issue 3:459‐72. [MEDLINE: ] - PubMed
Schou 1979 {published data only}
    1. Schou M. Lithium as a prophylactic agent in unipolar affective illness: acomparison with cyclic antidepressants. Archives of General Psychiatry 1979;36(8 Spec No):849‐51. - PubMed
Shapiro 1989 {published data only}
    1. Shapiro DR, Quitkin FM, Fleiss JL. Response to maintenance therapy in bipolar illness. Effect of index episode. Archives of General Psychiatry. 46 1989; Vol. 46, issue 5:401‐5. [MEDLINE: ] - PubMed
Shelley 1974 {published data only}
    1. Shelley EM, Mendlewicz J, Fieve RR. Affective disease health maintenance organization. Patterns of lithium response. New York State Journal of Medicine. 74 1974; Vol. 74, issue 10:1766‐8. [MEDLINE: ] - PubMed
Stallone 1973 {published data only}
    1. Stallone F, Shelley E, Mendlewicz J, Fieve RR. The use of lithium in affective disorders. 3. A double‐blind study of prophylaxis in bipolar illness. American Journal of Psychiatry. 130 1973; Vol. 130, issue 9:1006‐10. [MEDLINE: ] - PubMed
STOP‐PD 2004 {published data only}
    1. Meyers B, Rothschild A, Gabriele M, English J, McShea M, Kamara T, et al. Acute pharmacotherapy of psychotic depression (STOP‐PD). ClinicalTrials.gov 2004.
Szuba 1994 {published data only}
    1. Szuba MP, Baxter LR Jr, Altshuler LL, Allen EM, Guze BH, Schwartz JM, et al. Lithium sustains the acute antidepressant effects of sleep deprivation: preliminary findings from a controlled study. Psychiatry Research 1994;51(3):283‐95. - PubMed
Watanabe 1975 {published data only}
    1. Watanabe S, Ishino H, Otsuki S. Double‐blind comparison of lithium carbonate and imipramine in treatment of depression. Archives of General Psychiatry. 32 1975; Vol. 32, issue 5:659‐68. [MEDLINE: ] - PubMed
Wilkinson 2002 {published data only}
    1. Wilkinson D, Holmes C, Woolford J, Stammers S, North J. Prophylactic therapy with lithium in elderly patients with unipolar major depression. International Journal of Geriatric Psychiatry 2002;17(7):619‐22. - PubMed
Worrall 1979 a {published data only}
    1. Worrall EP, Moody JP, Peet M, Dick P, Smith A, Chambers C, et al. Controlled studies of the acute antidepressant effects of lithium. British Journal of Psychiatry 1979;135:255‐62. - PubMed

Additional references

Bauer 1999
    1. Bauer M, Dopfmer, S. Lithium augmentation in treatment‐resistant depression: a meta‐analysis of placebo‐controlled studies. Journal of Clinical Psychopharmacology 1999;19:427‐34. - PubMed
Burgess 2001
    1. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database of Systematic Reviews 2001, Issue 3. - PubMed
Cipriani 2005
    1. Cipriani A, Wilder H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behaviour and all‐cause mortality in patients with mood disorders: a systematic review of randomised trials. American Journal of Psychiatry 2005;162(10):1805‐10. - PubMed
Clarke 1997 [Computer program]
    1. Clarke M, Oxman AD. Cochrane Reviewers' Handbook 4.0. Version 4.0. Oxford, UK: The Cochrane Collaboration, 1999.
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7:177‐88. - PubMed
Geddes 2000
    1. Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J. SSRIs versus other antidepressants for depressive disorder. The Cochrane Library 2000, Issue 3. - PubMed
Geddes 2003
    1. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361(9358):653‐61. - PubMed
Geddes 2004a
    1. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long‐term lithium therapy for bipolar disorder: systematic review and meta‐analysis of randomized controlled trials. American Journal of Psychiatry 2004;161(2):217‐22. - PubMed
Geddes 2004b
    1. Geddes J, Butler R, Hatcher S, Cipriani A, Price J, Carney S, et al. Depressive disorders. Clinical Evidence. London: BMJ Publishing Group, 2004:1391‐436. - PubMed
Gijsman 2004c
    1. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. American Journal of Psychiatry 2004;161(9):1537‐47. - PubMed
Greil 1996
    1. Greil W, Ludwig‐Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, et al. Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. Journal of Affective Disorders 1996;40(3):179‐90. - PubMed
Harris 1997
    1. Harris E, d Barraclough B. Suicide as an outcome for mental disorders. British Journal of Psychiatry 1997;170:205‐28. - PubMed
Juni 1999
    1. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta‐analysis. JAMA 1999;282(11):1054‐60. - PubMed
Kessler 1994
    1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Life‐time and twelve‐month prevalence of DSM‐III‐R psychiatric disorders in the United States: results from the National Co‐morbidity Survey. Archives of General Psychiatry 1994;51:8‐19. - PubMed
Klein 1980
    1. Klein D, Gittelman R, Quitkin F, Rifkin A. Diagnosis and drug treatment of psychiatric disorders: adults and children. Baltimore: Williams and Wilkins, 1980.
Murray 1997a
    1. Murray C, Lopez A. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436‐42. - PubMed
Murray 1997b
    1. Murray C, Lopez A. Alternative projections of mortality and disability by cause 1990‐2020. Lancet 1997;349:1498‐504. - PubMed
NIMH‐NIH 1985
    1. NIMH‐NIH Consensus Development Conference Statement. Mood disorders: prevention of recurrences. American Journal of Psychiatry 1985;142:469‐72. - PubMed
Souza 1991
    1. Souza FG, Goodwin GM. Lithium treatment and prophylaxis in unipolar depression: a meta‐analysis. British Journal of Psychiatry 1991;158:666‐75. - PubMed

Publication types

MeSH terms